Global Ankylosing Spondylitis Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

ID:PD035794
September 2019
GIR (Global Info Research)

Single User License: $ 3480.00 Multi User License: $ 5220.00 Enterprise License: $ 6960.00

Description
Table Of Content

The Global Ankylosing Spondylitis Drug Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.

Ankylosing spondylitis is a form of chronic inflammation of the spine and the sacroiliac joints.

Scope of the Report:
The worldwide market for Ankylosing Spondylitis Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019.

This report focuses on the Ankylosing Spondylitis Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Amgen
Wyeth
Takeda
Centocor
Schering-Plough
Mitsubishi Tanabe
Abbott
Eisai
Pfizer
Johnson & Johnson

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Cimzia
Enbrel
Humira
Remicade
Simponi
Others

Market Segment by Applications, can be divided into

Hospitals
Clinics

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ankylosing Spondylitis Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ankylosing Spondylitis Drug, with price, sales, revenue and global market share of Ankylosing Spondylitis Drug in 2017 and 2018.
Chapter 3, the Ankylosing Spondylitis Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ankylosing Spondylitis Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Ankylosing Spondylitis Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Ankylosing Spondylitis Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Ankylosing Spondylitis Drug Introduction
    1.2 Market Analysis by Type
        1.2.1 Cimzia
        1.2.2 Enbrel
        1.2.3 Humira
        1.2.4 Remicade
        1.2.5 Simponi
        1.2.6 Others
    1.3 Market Analysis by Applications
        1.3.1 Hospitals
        1.3.2 Clinics
    1.4 Market Analysis by Regions
        1.4.1 North America (United States, Canada and Mexico)
            1.4.1.1 United States Market States and Outlook (2014-2024)
            1.4.1.2 Canada Market States and Outlook (2014-2024)
            1.4.1.3 Mexico Market States and Outlook (2014-2024)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2014-2024)
            1.4.2.2 France Market States and Outlook (2014-2024)
            1.4.2.3 UK Market States and Outlook (2014-2024)
            1.4.2.4 Russia Market States and Outlook (2014-2024)
            1.4.2.5 Italy Market States and Outlook (2014-2024)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2014-2024)
            1.4.3.2 Japan Market States and Outlook (2014-2024)
            1.4.3.3 Korea Market States and Outlook (2014-2024)
            1.4.3.4 India Market States and Outlook (2014-2024)
            1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2014-2024)
            1.4.4.2 Egypt Market States and Outlook (2014-2024)
            1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
            1.4.4.4 South Africa Market States and Outlook (2014-2024)
            1.4.4.5 Turkey Market States and Outlook (2014-2024)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Amgen
        2.1.1 Business Overview
        2.1.2 Ankylosing Spondylitis Drug Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 Amgen Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.2 Wyeth
        2.2.1 Business Overview
        2.2.2 Ankylosing Spondylitis Drug Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Wyeth Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.3 Takeda
        2.3.1 Business Overview
        2.3.2 Ankylosing Spondylitis Drug Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 Takeda Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.4 Centocor
        2.4.1 Business Overview
        2.4.2 Ankylosing Spondylitis Drug Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Centocor Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.5 Schering-Plough
        2.5.1 Business Overview
        2.5.2 Ankylosing Spondylitis Drug Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 Schering-Plough Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.6 Mitsubishi Tanabe
        2.6.1 Business Overview
        2.6.2 Ankylosing Spondylitis Drug Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.7 Abbott
        2.7.1 Business Overview
        2.7.2 Ankylosing Spondylitis Drug Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Abbott Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.8 Eisai
        2.8.1 Business Overview
        2.8.2 Ankylosing Spondylitis Drug Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 Eisai Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.9 Pfizer
        2.9.1 Business Overview
        2.9.2 Ankylosing Spondylitis Drug Type and Applications
            2.9.2.1 Product A
            2.9.2.2 Product B
        2.9.3 Pfizer Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.10 Johnson & Johnson
        2.10.1 Business Overview
        2.10.2 Ankylosing Spondylitis Drug Type and Applications
            2.10.2.1 Product A
            2.10.2.2 Product B
        2.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Ankylosing Spondylitis Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
    3.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Manufacturer (2017-2018)
    3.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Manufacturer (2017-2018)
    3.3 Market Concentration Rate
        3.3.1 Top 3 Ankylosing Spondylitis Drug Manufacturer Market Share in 2018
        3.3.2 Top 6 Ankylosing Spondylitis Drug Manufacturer Market Share in 2018
    3.4 Market Competition Trend
4 Global Ankylosing Spondylitis Drug Market Analysis by Regions
    4.1 Global Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Regions
        4.1.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Regions (2014-2019)
        4.1.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Regions (2014-2019)
    4.2 North America Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    4.3 Europe Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    4.4 Asia-Pacific Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    4.5 South America Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    4.6 Middle East and Africa Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
5 North America Ankylosing Spondylitis Drug by Country
    5.1 North America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Country
        5.1.1 North America Ankylosing Spondylitis Drug Sales and Market Share by Country (2014-2019)
        5.1.2 North America Ankylosing Spondylitis Drug Revenue and Market Share by Country (2014-2019)
    5.2 United States Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    5.3 Canada Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    5.4 Mexico Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
6 Europe Ankylosing Spondylitis Drug by Country
    6.1 Europe Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Country
        6.1.1 Europe Ankylosing Spondylitis Drug Sales and Market Share by Country (2014-2019)
        6.1.2 Europe Ankylosing Spondylitis Drug Revenue and Market Share by Country (2014-2019)
    6.2 Germany Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    6.3 UK Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    6.4 France Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    6.5 Russia Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    6.6 Italy Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
7 Asia-Pacific Ankylosing Spondylitis Drug by Country
    7.1 Asia-Pacific Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Country
        7.1.1 Asia-Pacific Ankylosing Spondylitis Drug Sales and Market Share by Country (2014-2019)
        7.1.2 Asia-Pacific Ankylosing Spondylitis Drug Revenue and Market Share by Country (2014-2019)
    7.2 China Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    7.3 Japan Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    7.4 Korea Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    7.5 India Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    7.6 Southeast Asia Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
8 South America Ankylosing Spondylitis Drug by Country
    8.1 South America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Country
        8.1.1 South America Ankylosing Spondylitis Drug Sales and Market Share by Country (2014-2019)
        8.1.2 South America Ankylosing Spondylitis Drug Revenue and Market Share by Country (2014-2019)
    8.2 Brazil Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    8.3 Argentina Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    8.4 Colombia Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
9 Middle East and Africa Ankylosing Spondylitis Drug by Countries
    9.1 Middle East and Africa Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Country
        9.1.1 Middle East and Africa Ankylosing Spondylitis Drug Sales and Market Share by Country (2014-2019)
        9.1.2 Middle East and Africa Ankylosing Spondylitis Drug Revenue and Market Share by Country (2014-2019)
    9.2 Saudi Arabia Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    9.3 Turkey Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    9.4 Egypt Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    9.5 Nigeria Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
    9.6 South Africa Ankylosing Spondylitis Drug Sales and Growth Rate (2014-2019)
10 Global Ankylosing Spondylitis Drug Market Segment by Type
    10.1 Global Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Type (2014-2019)
        10.1.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Type (2014-2019)
        10.1.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Type (2014-2019)
    10.2 Cimzia Sales Growth and Price
        10.2.1 Global Cimzia Sales Growth (2014-2019)
        10.2.2 Global Cimzia Price (2014-2019)
    10.3 Enbrel Sales Growth and Price
        10.3.1 Global Enbrel Sales Growth (2014-2019)
        10.3.2 Global Enbrel Price (2014-2019)
    10.4 Humira Sales Growth and Price
        10.4.1 Global Humira Sales Growth (2014-2019)
        10.4.2 Global Humira Price (2014-2019)
    10.5 Remicade Sales Growth and Price
        10.5.1 Global Remicade Sales Growth (2014-2019)
        10.5.2 Global Remicade Price (2014-2019)
    10.6 Simponi Sales Growth and Price
        10.6.1 Global Simponi Sales Growth (2014-2019)
        10.6.2 Global Simponi Price (2014-2019)
    10.7 Others Sales Growth and Price
        10.7.1 Global Others Sales Growth (2014-2019)
        10.7.2 Global Others Price (2014-2019)
11 Global Ankylosing Spondylitis Drug Market Segment by Application
    11.1 Global Ankylosing Spondylitis Drug Sales Market Share by Application (2014-2019)
    11.2 Hospitals Sales Growth (2014-2019)
    11.3 Clinics Sales Growth (2014-2019)
12 Ankylosing Spondylitis Drug Market Forecast (2019-2024)
    12.1 Global Ankylosing Spondylitis Drug Sales, Revenue and Growth Rate (2019-2024)
    12.2 Ankylosing Spondylitis Drug Market Forecast by Regions (2019-2024)
        12.2.1 North America Ankylosing Spondylitis Drug Market Forecast (2019-2024)
        12.2.2 Europe Ankylosing Spondylitis Drug Market Forecast (2019-2024)
        12.2.3 Asia-Pacific Ankylosing Spondylitis Drug Market Forecast (2019-2024)
        12.2.4 South America Ankylosing Spondylitis Drug Market Forecast (2019-2024)
        12.2.5 Middle East and Africa Ankylosing Spondylitis Drug Market Forecast (2019-2024)
    12.3 Ankylosing Spondylitis Drug Market Forecast by Type (2019-2024)
        12.3.1 Global Ankylosing Spondylitis Drug Sales Forecast by Type (2019-2024)
        12.3.2 Global Ankylosing Spondylitis Drug Market Share Forecast by Type (2019-2024)
    12.4 Ankylosing Spondylitis Drug Market Forecast by Application (2019-2024)
        12.4.1 Global Ankylosing Spondylitis Drug Sales Forecast by Application (2019-2024)
        12.4.2 Global Ankylosing Spondylitis Drug Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source

Related Categories

Pharmaceuticals

Get Custom Research at price of Syndicate

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..

Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks read more..

Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on read more..

Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides read more..

Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under read more..

Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also read more..

Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and read more..

Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and read more..

Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..

Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also read more..